EP4626890A1 — Ribociclib salts and formulations thereof
Assigned to KRKA dd · Expires 2025-10-08 · 1y expired
What this patent protects
29 KRK0017-WO Abstract: The invention relates to physiologically acceptable acid addition salts of Ribociclib and pharmaceutical compositions thereof. In particular, the invention relates to tablet formulations containing Ribociclib malate monohydrate, Ribociclib hydrochloride di…
USPTO Abstract
29 KRK0017-WO Abstract: The invention relates to physiologically acceptable acid addition salts of Ribociclib and pharmaceutical compositions thereof. In particular, the invention relates to tablet formulations containing Ribociclib malate monohydrate, Ribociclib hydrochloride dihydrate or Ribociclib hydrochloride anhydrate.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.